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Abstract
Introduction: Autosomal dominant polycystic kidney disease is an inherited disorder that is characterized by the 
development and growth of cysts in the kidneys and other organs. Urinary protein excretion is usually less than 1 g/24 
hours in autosomal dominant polycystic kidney disease, and an association of nephrotic syndrome with this condition 
is considered rare. There are only anecdotal case reports of autosomal dominant polycystic kidney disease associated 
with nephrotic syndrome, with focal segmental glomerulosclerosis being the most commonly reported 
histopathological diagnosis. Nephrotic-range proteinuria in the presence of autosomal dominant polycystic kidney 
disease, with or without an accompanying decline in renal function, should be investigated by open renal biopsy to 
exclude coexisting glomerular disease. To the best of our knowledge, this is the first case of autosomal dominant 
polycystic kidney disease with histologically proven diffuse proliferative glomerulonephritis presenting with nephrotic-
range proteinuria. No other reports of this could be found in a global electronic search of the literature.
Case presentation: We report the case of a 35-year-old Indo-Aryan man with autosomal dominant polycystic kidney 
disease associated with nephrotic syndrome and a concomitant decline in his glomerular filtration rate. Open renal 
biopsy revealed diffuse proliferative glomerulonephritis. An accurate diagnosis enabled us to manage him 
conservatively with a successful outcome, without the use of corticosteroid which is the standard treatment and the 
drug most commonly used to treat nephrotic syndrome empirically.
Conclusion: Despite the reluctance of physicians to carry out a renal biopsy on patients with autosomal dominant 
polycystic kidney disease, our case supports the idea that renal biopsy is needed in patients with polycystic kidney 
disease with nephrotic-range proteinuria to make an accurate diagnosis. It also illustrates the importance of open renal 
biopsy in planning appropriate treatment for patients with autosomal dominant polycystic kidney disease with 
nephrotic-range proteinuria. The treatment for various histological subtypes leading to nephrotic syndrome is 
different, and in this modern era we should practice evidence-based medicine and should avoid empirical therapy 
with its associated adverse effects.
Introduction
In patients with autosomal dominant polycystic kidney
disease (ADPKD), urinary protein excretion is usually
less than 1 g/24 hours. If proteinuria reaches the neph-
rotic range, the possibility of another coexistent glomeru-
l a r  d i s e a s e  s h o u l d  a l w a y s  b e  c o n s i d e r e d .  I n  s u c h  a
situation, open renal biopsy is warranted to reach a firm
diagnosis. A review of the literature revealed only anec-
dotal case reports of ADPKD associated with nephrotic
syndrome, with focal segmental glomerulosclerosis
(FSGS) being the most commonly reported histopatho-
logical diagnosis. We report an unusual case of ADPKD
with diffuse proliferative glomerulonephritis (DPGN)
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and nephrotic-range proteinuria. This is the first docu-
mented case of ADPKD with DPGN as no other reports
of this could be found in a global electronic search of the
literature.
Case presentation
A 35-year-old Indo-Aryan man presented with facial
puffiness and dyspnea on exertion for two weeks. He
denied any history of abdominal pain, fever, dysuria,
smoky urine, gross hematuria, sore throat, skin infection,
joint pains, skin rash and oral ulcers. He was diagnosed
with ADPKD, and his mother also had the disease. A gen-
eral physical examination revealed his blood pressure was
170/110 mmHg and he had bilateral pitting pedal edema.
A systemic examination of our patient was unremarkable
except for bilaterally palpable knobby kidneys.
His blood test results showed the following: hemoglo-
bin 136 g/L, total leukocyte count 8200/mm3 (Neutro-
phils 65%, Lymphocytes 28%, Monocytes 5%, Eosinophils
2%), platelet count 2.5 × 105/mm3, blood urea nitrogen
6.6 mmol/L, serum creatinine 150 μmol/L, serum potas-
sium 3.8 mmol/L, serum albumin 30 g/L and serum cho-
lesterol 7.42 mmol/L. Urine analysis showed 3+ albumin,
and 20-25 leukocytes and 8-10 red blood cells per high
power field. His 24-hour urinary protein excretion was
4.67 g. Urine culture and throat swab culture were sterile.
Blood cultures on two separate occasions were also ster-
ile. Ultrasound analysis of the abdomen of our patient
showed an enlarged liver with multiple cysts and both
kidneys were enlarged with multiple cysts of varying sizes
(in both the cortex and medullary regions). Transthoracic
echocardiography was normal and did not reveal any veg-
etations. Serology for hepatitis B surface antigen and
anti-hepatitis C antibodies were non-reactive. Anti-
nuclear antibody (ANA) and anti-neutrophil cytoplasmic
antibody (ANCA) were shown as negative using the
immunofluorescence technique. Anti-streptolysin O
(ASO) titer was 350 Todd units. Serum complement (C3)
was 70 mg/dL (normal range 75-135 mg/dL) which
returned to normal levels at 12 weeks from the time of
diagnosis.
An open renal biopsy was carried out on our patient.
Under low magnification light microscopy, cysts lined by
flattened cells were observed. A total of 56 glomeruli
w e r e  see n wit h va ria ble  m esa ngia l h ype r c e ll ula ri ty  and
endocapillary proliferation with neutrophilic infiltration.
There was focal tubular atrophy, and focal lymphocytic
infiltrates were present in the interstitium. Blood vessels
revealed intimal sclerosis (Figures 1 and 2). Immunofluo-
rescence studies showed 20 glomeruli of which one was
sclerosed. Focal immunoglobulin G (IgG) deposits (+ to
++), traces of immunoglobulin M (IgM) along with dif-
fuse C3 (+++) deposits in a lumpy bumpy pattern were
seen in the glomeruli. A diagnosis of ADPKD with post-
streptococcal DPGN was made. Our patient was man-
aged conservatively. This included close monitoring of
his blood pressure, renal function tests and serum potas-
sium along with salt restriction, diuretics and antihyper-
tensive medications (losartan potassium and
amlodipine). Corticosteroid was not prescribed for our
patient. He improved over the next 12 weeks. His protei-
nuria returned to less than 1 g/24 hours with a normaliza-
tion of renal function and a reduction in the requirement
of antihypertensive medications.
Discussion
The frequency of occurrence of proteinuria in ADPKD
ranged from 14 to 34% in non-uremic adults to about 80%
Figure 1 Photomicrograph shows a cyst lined by flattened cells. 
Renal parenchyma shows four glomeruli, a focus of lymphocytic ag-
gregate in the interstitium and tubular atrophy. (hematoxylin and eo-
sin, 100×)
Figure 2 The glomerulus shows mesangial hypercellularity, en-
docapillary proliferation and neutrophilic infiltrate (hematoxylin 
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i n  a d u l t s  w i t h  a d v a n c ed  r e n a l  f a i l u r e  i n  t h e  r ev i ew  b y
Chapman  et al. [1]. When present in patients with
ADPKD, proteinuria is generally less than 1 g/24 hours.
In patients of ADPKD; nephrotic range proteinuria, with
or without an accompanying decline in renal function, is
unusual and needs to be investigated further to exclude
coexisting glomerular disease. Moreover, proteinuria has-
tens the progression of ADPKD to end-stage renal dis-
ease (ESRD) if it is untreated. Patients with established
proteinuria have significantly higher mean arterial pres-
sure, large renal volumes, lower creatinine clearances and
a more aggressive course. Even microalbuminuric
ADPKD patients with hypertension have a significantly
higher filtration fraction and larger renal volumes [1].
The presence of nephrotic-range proteinuria is excep-
tional in ADPKD, with less than 20 cases having been
reported in the literature so far. This may be due in part
to the reluctance of nephrologists to perform renal biopsy
in these patients, as this usually entails an open renal
biopsy. Dalgaard et al. [2] described three cases of protei-
nuria >5 g/day in a report of 122 cases with ADPKD.
Unfortunately renal biopsy data are not available in this
series.
The various histopathological lesions reported in
ADPKD patients are FSGS, membranous nephropathy,
minimal change disease, crescentic glomerulonephritis,
immunoglobulin A (IgA) nephropathy, mesangioprolifer-
ative glomerulonephritis, diabetic glomerulosclerosis and
amyloidosis. Various histological subtypes that have been
described in the literature are summarized in Table 1. A
review of the literature revealed focal glomerulosclerosis
to be the most common histological subtype associated
with ADPKD, followed by membranous nephropathy and
minimal change disease [3]. It is difficult to be certain
whether these associations are coincidental or whether
they demonstrate a specific pathogenetic relationship
w i t h  A D P KD .  T h e  f r e q u e n cy  o f  F S G S  i n  t h e  r e po r t ed
cases (5/18, 28%) is almost twice as high as the 15% fre-
quency of FSGS found in the general adult population. By
contrast, membranous nephropathy, the most common
cause of idiopathic nephrotic syndrome in adults, with a
frequency of 25%, was found in 16% (3/18) of the ADPKD
patients with nephrotic syndrome, which suggests that
FSGS may be more than a coincidental finding.
Glomerular hyperfiltration could play an important
role in the development of FSGS and heavy proteinuria in
patients with ADPKD. In a histological study of the kid-
neys of 12 ADPKD patients by Montoyo et al. [4], inter-
stitial fibrosis and tubular atrophy were found to be the
main determinants of the development of chronic renal
failure in ADPKD. In a study of 18 cases, Zeier et al. [5]
reported interstitial fibrosis and arteriolar sclerosis as
being the most important lesions in kidneys of ADPKD
patients, whereas FSGS was observed in less than 5% of
the glomeruli.
The index case was a diagnosed case of ADPKD who
presented with nephrotic-range proteinuria with active
urinary sediment. Open kidney biopsy was consistent
with DPGN. This association of ADPKD and DPGN has
not been described in the literature so far. Proteinuria is
usually less than 3 g/24 hours in more than 75% of
patients with DPGN, however it may reach the nephrotic
range in 20% of hospitalized patients. Open renal biopsy
in our case not only aided our prognostications, but also
helped us in reaching a definitive diagnosis. Biopsy report
enabled us to obviate the use of corticosteroids in our
patient, which is the usual modality of empirical therapy
in patients with nephrotic syndrome.
To the best of our knowledge, our patient was the first
ADPKD patient with nephrotic syndrome caused by
post-streptococcal DPGN. It might have been a chance
association, as both DPGN and ADPKD are common in
the general population, but nephrologists should be
aware of this potential association. Our case again illus-
trates the importance of open renal biopsy in patients
with polycystic kidney disease with nephrotic-range pro-
teinuria, as the treatment for various histopathological
subtypes leading to nephrotic syndrome is different and
in this modern era we should practice evidence-based
medicine. It also illustrates a way of avoiding empirical
therapy.
Conclusion
Clinicians are reluctant to perform renal biopsy in
patients of ADPKD as it entails an open renal biopsy
which requires the involvement of a surgeon. However,
our case reinforces the need for renal biopsy in patients
with polycystic kidney disease presenting with nephrotic-
range proteinuria to exclude any coexisting glomerular
disease, and to reach an accurate diagnosis. It also illus-
trates the importance of open renal biopsy in patients
with ADPKD and nephrotic-range proteinuria in order to
plan appropriate treatment. Treatment for various histo-
pathological subtypes leading to nephrotic syndrome is
different. Corticosteroids are beneficial in some condi-
tions whereas they may not be of any use in other cases. A
lesson to be learnt from our case is that an open renal
biopsy should be carried out in all patients with ADPKD
presenting with nephrotic syndrome to make an accurate
diagnosis. Reaching a firm diagnosis based on histopa-
thology and immunofluorescence studies will help the
physician to give appropriate treatment in the form of
corticosteroids and/or cytotoxic agents, if indicated, and
to avoid empirical therapy with these potentially toxic
agents and to avoid their possible adverse effects.D'Cruz et al. Journal of Medical Case Reports 2010, 4:125
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